Recruiting

Observational Study

Sponsor:

Stanford University

Code:

NCT00398177

Conditions

Lymphoma, Non-Hodgkin

Hodgkin's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Conditions

Lymphoma, Non-Hodgkin

Hodgkin's Disease

Study ID

NCT00398177

Start date

Jan, 1999

Status verified date

Dec, 2025

Completion date

Jan, 2099

Anticipated

Primary completion date

Jan, 2099

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
  • Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
  • A routine procedure for tissue collection is planned.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

  • Patients without NHL or Hodgkin's disease

Study Design

Enrollment

9999 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma. [ Time Frame: The study will continue indefinitely. ]

Central Contacts and Locations

Central contacts

Alyssa M Kanegai

650-736-1596akanegai@stanford.edu

Locations

Stanford University School of Medicine

Recruiting

Stanford, California, United States, 94305

Contacts

Alyssa M Kanegai

650-736-1596akanegai@stanford.edu

Principal Investigator:

Ronald Levy

More Information

Sponsor

Stanford University

Last update posted

Dec 24, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Stanford University on 2025-12-24.